Skip to main content

1 Result(s)

within Michaela Bitzenhofer Remove this filter

and

  1. Article

    Open Access

    Real-World Use, Safety, and Patient Experience of 20% Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases

    The CORE study aimed to provide a detailed understanding of real-world immune globulin subcutaneous (human) 20% solution (Ig20Gly) utilization in patients with primary immunodeficiency diseases (PIDs) in Germa...

    Maria Fasshauer, Michael Borte, Michaela Bitzenhofer… in Advances in Therapy (2023)

    Download PDF (1256 KB) View Article